In this regard, a short-term (1 wk) CSF-1R inhibition with subsequent brain repopulation during glioma progression led to a significant reduction in tumor volume as quantified by both gadolinium-enhanced MRI and 18F-FET PET. This evidence concerns the gene CSF1R and central nervous system cancer.